american cancer society proposal centralamerican cancer society proposal central

Call us at 800-227-2345 or live chat with questions. ACS Research and Clinical Research Professors. Or ask us how you can get involved and support the fight against cancer. English, Is a Cancer Treatment Clinical Trial the Right Choice for Me? 15 Mortality data were . Established under the National Cancer Institute Act of 1937, NCI is part of the National Institutes of Health (NIH), one of 11 agencies that make up the Department of Health and Human Services (HHS). Ensure that the PI enables access for whichever OPAMdirector and pre-award administrator are handling the proposal. Accessibility Health Equity Research in Cancer Control & Prevention, Clinician Scientist Development Grant (CSDG), St. Baldrick's Foundation - ACS Childhood Cancer Research RFA: Pilot Accelerator Award, Cancer Health Equity Research Centers (CHERCs), The Role of Health Policy and Health Insurance in Improving Access to, and Performance of, Cancer Care, ACS-Wilmott Family Professorship in Pancreatic Cancer, Referrals to patient-related programs or resources, Donations, website, or event-related assistance. Background: Large-scale, prospective cohort studies have played a critical role in discovering factors that contribute to variability in cancer risk in human populations. The principal investigator of the grant should be a senior faculty member. In fact, ACS is the only organization that . All Patient Programs and Services Overall Impact of the American Cancer Society We welcome projects along the cancer research continuum, especially those integrating multi-disciplinary approaches with near-term clinical impact. Background for the interdisciplinary research plan. +We anticipate that the work of these individuals and of the collaborative community, will improve the scientific communitys ability to detect and target cancer stem cells and influence the development of much-needed, personalized and durable cancer treatments. This is a joint special opportunity Young Investigator Award with the Melanoma Research Alliance (MRA) to support research in radiation oncology to improve treatment options for melanoma patients. The fellow can expect to work with Varian in the research and development area(s) of: radiobiology, immunotherapy, applications of artificial intelligence in radiation oncology, information systems, treatment planning, imaging and image-guidance, new hardware for treatment delivery systems and quality assurance. Underrepresented Populations in the U.S. Biomedical, Clinical, Behavioral and Social Sciences Research Enterprise ASTRO funds research for junior faculty, residents, fellows and postdoctoral fellows in support of radiation oncology researchers careers. We use cookies to provide, secure and improve our services to you. ABOUT AACR RESEARCH FUNDING. An official website of the United States government. The fellow will also gain experience in medical affairs and will work with scientific experts globally in radiation, and medical oncology. Referrals to patient-related programs or resources, Donations, website, or event-related assistance. Link to ProposalCentral: https://proposalcentral.altum.com/default.asp. Featured: Have cancer and want to quit smoking? Expert Predictions: Cancer Care 10 Years from Now, Nobel Laureates and the American Cancer Society, How Epigenetics Could Improve Your Cancer Treatment, American Cancer Society Awards Medal of Honor for Extraordinary Contributions for Saving Lives from Cancer, Seven Breast Cancer Research Success Stories, A New Intervention for Improving Health After Cancer, ACS Mini Symposium May 2022: Translation of Cancer Research to Human Testing, Future Defenses Against Colorectal Cancer May Include a Vaccine and Genetic Engineering, Press Release: American Cancer Society Awards Research Professorships, Researchers Look for Ways to Improve Communication Between Cancer Patients and Doctors, Patient Navigators Can Help When Life Disrupts Cancer Care, A World Leader in Infection-Related Cancer Research: ACS Professor Profile, HPV Vaccine: A Powerful Way to Help Prevent 3+ Cancers in Women, "Cancer is basically a non-healing wound and we should treat it as such", Improving Precision Therapies for Non-Small Cell Lung Cancer, ACS Research Professor Recognized for Outstanding Achievement in Breast Cancer Research, American Cancer Society Research Professor Makes Strides Against Breast Cancer, American Cancer Society Funded Researchers Win Lasker Award, Class, Race, and Cancer: Unraveling the Complex Connections, Matthew Meyerson (Mentor) and Alison Taylor (Mentee), Personlized Cancer Care: Where It Stands Today, A Pioneer for Developing Drugs for People with T-Cell Lymphoma, Childhood Cancer Research Challenges and Opportunities: A Roundtable Discussion, Changing the Shape of Leukemia Research and Clinical Care, Improving Quality of Life for Lung Cancer Survivors, Referrals to patient-related programs or resources, Donations, website, or event-related assistance. There are 201 currently active grant application cycles in ProposalCentral! The AACR . At our National Cancer Information Center trained Cancer Information Specialists can answer questions 24 hours a day, every day of the year to empower you with accurate, up-to-date information to help you make educated health decisions. Featured: Have cancer and want to quit smoking? Herein, the American Cancer Society provides its biennial update of the latest breast cancer statistics in the United States, including the estimated numbers of new cases and deaths by age in 2019; incidence rates and trends by age, stage at diagnosis, race/ethnicity, and breast cancer molecular subtype through 2016; mortality rates and trends b. To see local mailing address options, select your state. Have expertise in cancer stem cells or in another discipline that is central to the proposed research. Tax ID Number: 13-1788491. Cancer.org is provided courtesy of the Leo and Gloria Rosen family. Learn more about cancer occurrence and survival, as well as symptoms, prevention, early detection and treatment. At the ACS, the largest private non-profit funder of cancer research in the United States, the average success rate for grant applications has slipped by a few percentage points in the past two. Targeted candidates are medical physicists or clinicians with backgrounds in engineering or the exact sciences (physics, math, computer sciences). But cancer stem cells, a small subset of cells within tumors, have an exquisite ability to change the way they look and function, allowing them to hide from the immune system, evade destruction by cancer drugs or irradiation, and also to metastasize. Tax ID Number: 13-1788491. Before The first time you log in, follow the instructions in the Login Instructions (PDF) to link your AHA account to ProposalCentral. Copyright @2007-2023Altum, Inc. All rights reserved 2023.5.19.145 | Privacy Policy. See Cancer Stem Cell Consortium Instructions PDFand Cancer Stem Cell Consortium Policies PDF. See if you're eligible for a clinical trial. We connect patients, caregivers, and family members with valuable services and resources. government site. If you do NOT see the application listed, there are two possibilities: Option 1: You have multiple accounts in ProposalCentral and the PI gave you access under a different account. $25 Billion Funded Grants. Applications are to be submitted via the MRA portal. Research We Fund: Extramural Discovery Science, Making Strides Against Breast Cancer Walks, Volunteer Opportunities for Organizations, Making Strides Against Breast Cancer Walk, Featured: Making Strides Against Breast Cancer, Center for Diversity in Cancer Research (DICR) Training. Applicants (PhD or equivalent) must be a postdoctoral fellow or medical physics resident, and be a member of ASTRO and AAPM or have applied for the respective memberships at the time of application. The American Cancer Society ( ACS) is a nationwide voluntary health organization dedicated to eliminating cancer. You can create your own profile using the tutorials on their site. The selected research team includes interdisciplinary members to promote transformational advances in cancer stem cell research. The team must consist of at least 3 members: Lead PI and at least 1 Team Principal and 1 Team Investigator. 4).Additional cancer incidence data for trends come from the Cancer Incidence in Five Continents (CI5) database of the International Association of . ASTRO-ACS Clinician Scientist Development Grant Application Deadline: March 24, 2023; 11:59 p.m. Eastern time. ASTRO-AstraZeneca Radiation Oncology Research Training Fellowships At our National Cancer Information Center trained Cancer Information Specialists can answer questions 24 hours a day, every day of the year to empower you with accurate, up-to-date information to help you make educated health decisions. PSA velocity was proposed as a risk factor for prostate cancer first in 1992 by Carter et al in a study of patients from the Baltimore Longitudinal Study of . When mailing a donation, please include details about how you would like your gift applied. The awards are intended to provide preeminent cancer researchers with flexibility to investigate innovative avenues of study. Applicants from underrepresented groups and from Minority-Serving Institutions (MSIs) are encouraged to apply. This is a joint effort with the American Cancer Society (ACS) to co-fund one Clinician Scientist Development Grant (CSDG). DaRT System CiNA DATA PRODUCTS OVERVIEW NAACCR receives de-identified population-based cancer data from member registries across the US and Canada. Funding:3 to 5 years with $135K direct costs a year, plus 8% allowable indirect costs. 1. The American Cancer Society is the largest, not-for-profit funding source for cancer research in the United States. AHA ProposalCentral. Since the inception of its extramural grants program in 1946, the Society has awarded more than $2.2 billion to cancer researchers, clinician-scientists, nurses, and social workers. Epidemiologists and volunteers at the American Cancer Society (ACS) were among the first to establish such cohorts, beginning in the early 1950s and continuing through the present, and these ACS cohorts have made landmark . The Eligibility Checklist must be submitted by October 19, 2022. Purpose:To advance innovative translational pediatric cancer research conducted within the context of a clinical trial. Applications Open in proposalCENTRAL: January 2022, Interactive Webinar to Learn More: January 31, from 12 to 1 EST (Webinar will be recorded and available upon request. Application Deadline: February 10, 2023; 11:59 p.m. Eastern time. ProposalCentral The American Cancer Society, The American Heart Association, and other major non-profits use this proposal submission portal Link to ProposalCentral: https://proposalcentral.altum.com/default.asp UMass is already a registered institution. The American Cancer Society makes significant investments in cancer research, advocacy, and patient support, including information and education on prevention and early detection as well as treatment options. Eligible Individuals (Principal Investigators (PIs)) Funding:5-year term with $80K a year; renewable While the grant term is 5 to 10 years, those awarded may use the title ACS Research Professor for the remainder of their careers., Chief Scientific Officer, Discovery Science, Grant Institution: Columbia University Irving Comprehensive Cancer Center in New York City, New York Grant Term: 1/1/2012 through 12/31/2021 Area of Research: Molecular Determinants of Prostate Cancer Progression Current Institution: Herbert Irving Comprehensive Cancer Center in New York City, New York, Grant Institution: UC San Diego in California Grant Term: 7/1/1988 through 6/30/1989 Area of Research: Hematology Current Institution: UC San Diego Health in California, Grant Institution: The Regents of the University of California, San Francisco Grant Term: 1/1/1981 through 10/31/1995 Area of Research: Molecular Biology Current Institution: University of California, San Francisco, Grant Institution: Dana-Farber Cancer Institute in Boston, MA Grant Term: 7/1/2010 through 6/30/2020 Area of Research: Cell Biology Current Institution: Dana-Farber Cancer Institute in Boston, MA Expert Predictions: Cancer Care 10 Years from Now, Grant Institution: Vanderbilt University Medical Center in Nashville, TN Grant Term: 7/1/2007 through 6/30/2017 Area of Research: Cellular and Molecular Biology Current Institution: UT Southwestern Medical Center in Dallas, TX, Grant Institution: California Institute of Technology in Pasadena, CA Grant Term: 1/1/1973 through 12/31/1997 Area of Research: Virology Current Institution: California Institute of Technology in Pasadena, CA Nobel Laureates and the American Cancer Society, Grant Institution: Harvard Medical School in Boston, MA Grant Term: 1/1/1990 through 12/31/2002 Area of Research: Microbiology and Immunology Current Institution: Harvard Medical School in Boston, MA, Grant Institution: Duke University Medical Center in Durham, NC Grant Term: 1/1/2006 through 6/30/2016 Area of Research: Cell Biology Current Institution: Duke University Medical Center in Durham, NC Expert Predictions: Cancer Care 10 Years from Now, Grant Institution: Fred Hutchinson Cancer Research Center in Seattle, WA Grant Term: 7/1/1995 through 6/30/2010 Area of Research: Immunology and Immuno-oncology Current Institution: Fred Hutchinson Cancer Research Center in Seattle, WA, Grant Institution: Massachusetts General Hospital in Boston Grant Term: 1/1/2016 through 12/31/2025 Area of Research: Molecular Genetics and Biochemistry Current Institution: Dana Farber Cancer Institute in Boston Press Release: New ACS Professors How Epigenetics Could Improve Your Cancer Treatment, Grant Institution: Rutgers Cancer Institute of New Jersey in New Brunswick Grant Term: 7/1/1975 through 6/30/1995 Area of Research: Hematology Current Institution: Rutgers Cancer Institute of New Jersey in New Brunswick, Grant Institution: Memorial Sloan-Kettering Cancer Center in New York City, NY Grant Term: 1/1/1977 through 3/31/1994 Area of Research: Immunology and immuno-oncology Last Institution: University of Arizona in Tucson, Grant Institution: Harvard Medical School in Boston, MA Grant Term: 1/1/2001 through 7/31/2004 Area of Research: Cellular Pathways That Control Cell Proliferation, Survival, and Invasion Current Institution: Harvard Medical School in Boston, MA American Cancer Society Awards Medal of Honor for Extraordinary Contributions for Saving Lives from Cancer, Grant Institution: Cold Spring Harbor Laboratory in New York Grant Term: 1/1/1969 through 6/30/1989 Area of Research: Molecular Biology Last Institution: Harvard School of Public Health in Boston, MA, Grant Institution: University of California, Santa Barbara Grant Term: 1/1/1990 through 12/31/1999 Area of Research: Molecular and Cellular Biology Current Institution: University of California, Santa Barbara, Grant Institution: University of Colorado, Denver Grant Term: 1/1/1987 through 12/31/1991 Area of Research: Molecular Biology Current Institution: University of Colorado, Boulder Nobel Laureates and the American Cancer Society, Grant Institution: Massachusetts General Hospital in Boston Grant Term: 1/1/2022 through 6/30/2027 Area of Research: Clinical and Translational Cancer Epidemiology Current Institution:Massachusetts General Hospital in Boston, Grant Institution: University of Pittsburgh in Pennsylvania Grant Term: 1/1/2009 through 12/31/2018 Area of Research: Discovery and Characterization of Novel Human Tumor Viruses Current Institution: University of Pittsburgh Cancer Institute in Pennsylvania The Cancer Atlas: Infection, Grant Institution: The University of Alabama at Birmingham Grant Term: 1/1/2011 through 4/30/2017 Area of Research: Establishment of an MEN2 Thyroid Cancer Research and Training Program Current Institution: The University of Alabama at Birmingham, Grant Institution: University of Michigan in Ann Arbor Grant Term: 7/1/2009 through 6/30/2019 Area of Research: A Bioinformatics Platform for Nextgen Sequencing in Oncology Current Institution: University of Michigan Health System in Ann Arbor, Grant Institution: Stanford University in California Grant Term: 1/1/2019 through 12/31/2023 Area of Research: Replication Stress and Genome Instability in Cancer Current Institution: Stanford University in California Podcast: When DNA and RNA Tangle, Grant Institution: Tufts University in Medford, MA Grant Term: 1/1/1994 through 12/31/2014 Area of Research: Molecular Biology of Retroviruses Current Institution: Tufts University in Medford, MA and National Cancer Institute in Bethesda, MD, Grant Institution: State University of New York at Stony Brook Grant Term: 9/1/1957 through 3/31/1992 Area of Research: Virology Last Institution: Rockefeller Institute, Grant Institution: Vanderbilt University School of Medicine in Nashville, TN Grant Term: 1/1/1976 through 3/31/1992 Area of Research: Molecular Biology Last Institution: Vanderbilt University in Nashville, TN Nobel Laureates and the American Cancer Society Seven Breast Cancer Research Success Stories, Grant Institution: Washington University, St. Louis in Missouri Grant Term: 7/1/2003 through 6/30/2014 Area of Research: Breast Cancer Epidemiology and Prevention Current Institution: Washington University, St. Louis in Missouri, Grant Institution: Vanderbilt University in Nashville, TN Grant Term: 7/1/1959 through 6/30/1983 Area of Research: Metabolic Biochemistry Last Institution: Vanderbilt University in Nashville, TN, Grant Institution:Yale University in New Haven,Connecticut Grant Term: 1/1/2019 through 12/31/2023 Area of Research: Molecular, Cellular, and Developmental Biology Current Institution: Yale University in New Haven, Connecticut, Grant Institution: Dana-Farber Cancer Institute in Boston, MA Grant Term: 2003 through current Area of Research: Molecular Biology Current Institution: Dana-Farber Cancer Institute in Boston, MA, Grant Institution: The Rockefeller University in New York City, NY Grant Term: 1/1/2010 through 12/31/2019 Area of Research: The Role of Telomere Dynamics in Human Cancer CurrentInstitution: Rockefeller University in New York City, NY, Grant Institution: Wistar Institute in Philadelphia, PA Grant Term: 1/1/1973 through 11/30/1994 Area of Research: Virology Last Institution: New York University Langone Medical Center in New York City, Grant Institution: The University of Alabama at Birmingham Grant Term: 7/1/2014 through 12/31/2024 Area of Research: Behavioral Science Current Institution: University of Alabama Comprehensive Cancer Center in Birmingham A New Intervention for Improving Health After Cancer, Grant Institution: Dana-Farber Cancer Institute in Boston, MA Grant Term: 1/1/1999 through 12/31/2008 Area of Research: Basic and Translational Research Current Institution: MD Anderson Cancer Center in Houston, TX ACS Mini Symposium May 2022: Translation of Cancer Research to Human Testing, Grant Institution: University of Washington in Seattle Grant Term: 7/1/2015 through 8/31/2025 Area of Research: Vaccines Targeting Cancer Initiation Antigens to Prevent Colon Cancer Current Institution: University of Washington in Seattle Future Defenses Against Colorectal Cancer May Include a Vaccine and Genetic Engineering Press Release: American Cancer Society Awards Research Professorships, Grant Institution: Dartmouth College in Hanover, NH Grant Term: 7/1/2008 through 6/30/2014 Area of Research: Bidirectional Translational Research for Lung Cancer Current Institution: Leidos Biomedical Research in Frederick, MD Expert Predictions: Cancer Care 10 Years from Now, Grant Institution: Fred Hutchinson Cancer Research Center in Seattle, WA Grant Term: 1/1/1997 through 12/31/2006 Area of Research: Control of Cell Proliferation by the Max Transcription Factor Network Current Institution: Fred Hutchinson Cancer Research Center in Seattle, WA, Grant Institution: Pennsylvania State University in University Park, PA Grant Term: 1/1/2009 through 12/31/2018 Area of Research: Molecularly Targeted Therapy for Colon and Liver Cancer CurrentInstitution: Fox Chase Cancer Center in Philadelphia, PA Expert Predictions: Cancer Care 10 Years from Now, Grant Institution: Cleveland Clinic Foundation in Ohio Grant Term: 7/1/2009 through 6/30/2019 Area of Research: Molecular Biology Current Institution: The Cleveland Clinic in Ohio Expert Predictions: Cancer Care 10 Years from Now, Grant Institution: Harvard University in Cambridge, MA Grant Term: 9/1/1959 through 6/30/1976 Area of Research: Biosynthesis of Estrogens Current Institution: Harvard University in Cambridge, MA, Grant Institution: University of Rochester Grant Term: 7/1/2018 through 6/30/2023 Area of Research: Communication, Mindfulness, and Patient Centered Care in Advanced Cancer Current Institution: University of Rochester in New York Researchers Look for Ways to Improve Communication Between Cancer Patients and Doctors, Grant Institution: Harvard University in Cambridge, MA Grant Term: 1/1/1993 through 6/30/2006 Area of Research: Protein Tyrosine Phosphatases Current Institution: Harvard University in Cambridge, MA, Grant Institution: Temple University of The Commonwealth System of Higher Education in Philadelphia, PA Grant Term: 7/1/1959 through 10/31/1985 Area of Research: Carcinogenesis Last Institution: University of Toronto in Ontario, Grant Institution: University of Michigan Medical Center in Ann Arbor Grant Term: 7/1/2008 through 6/30/2018 Area of Research: Novel Strategies to Treat Graft Versus Host Disease Current Institution: Icahn School of Medicine at Mount Sinai in New York City, NY, Grant Institution: Whitehead Institute for Biomedical Research in Cambridge, MA Grant Term: 1/1/1983 through 12/31/1992 Area of Research: Molecular Biology Current Institution: Whitehead Institute, Massachusetts Institute of Technology in Cambridge, MA, Grant Institution: Tufts Medical Center Inc. in Boston, MA Grant Term: 7/1/2012 through 6/30/2022 Area of Research: Patient Navigation to Eliminate Cancer Disparities Last Institution: Tufts Medical Center in Boston, MA Podcast: On Mentoring Expert Predictions: Cancer Care 10 Years from Now Patient Navigators Can Help When Life Disrupts Cancer Care, Grant Institution:Wistar Institute in Philadelphia, Pennsylvania Grant Term:1/1/2020 through 12/31/2024 Area of Research:Regulation of Tumor Development and Progression by Myeloid Cells Current Institution:Wistar Institute in Philadelphia, Pennsylvania, Grant Institution: University of Chicago in Illinois Grant Term: 7/1/2016 through 6/30/2021 Area of Research: Integrative Genomics to Identify Resistance Mechanisms to Immunotherapy Current Institution: University of Chicago in Illinois, Grant Institution: Carnegie Institution of Washington DC Grant Term: 1/1/1994 through 4/30/1998 Area of Research: Nuclear Structure and Function Current Institution: Carnegie Institute for Science in Baltimore, MD, Grant Institution: University of California, Los Angeles Grant Term: 7/1/1999 through 6/30/2010 Area of Research: Enhancing Patient Outcomes Across the Cancer Control Continuum Current Institution: UCLA Jonsson Comprehensive Cancer Center, Grant Institution: Harvard University in Cambridge, MA Grant Term: 7/1/1972 through 6/30/1998 Area of Research: Molecular Biology Current Institution: Harvard University in Cambridge, MA Nobel Laureates and the American Cancer Society, Grant Institution:H. Lee Moffitt Cancer Center and Research Institute, Inc. Grant Term:7/1/2018 through 6/30/2023 Area of Research:Prevention of Infection-Related Cancers Current Institution:H. Lee Moffitt Cancer Center and Research Institute, Inc. A World Leader in Infection-Related Cancer Research: ACS Professor Profile HPV Vaccine: A Powerful Way to Help Prevent 3+ Cancers in Women, Grant Institution: Harvard University in Cambridge, MA Grant Term: 9/1/1962 through 11/27/1973 Area of Research: Molecular Biology Last Institution: Harvard Medical School in Cambridge, MA, Grant Institution: University of Texas in Austin, TX Grant Term: 9/1/1961 through 8/31/1982 Area of Research: Carcinogenesis Last Institution: University of Texas MD Anderson Cancer Center in Houston, Grant Institution: The Regents of the University of California, San Francisco Grant Term: 1/1/1992 through 6/30/2016 Area of Research: mRNA Splicing and Transport; Mechanisms and Regulation Current Institution: University of California, San Francisco School of Medicine, Grant Institution: Massachusetts General Hospital in Boston Grant Term: 7/1/2022 through 6/09/2027 Area of Research:Equity Across the Cancer Continuum Current Institution:Massachusetts General Hospital in Boston, Grant Institution: University of Southern California in Los Angeles Grant Term: 1/1/1972 through 3/31/1992 Area of Research: Paraneoplastic Syndromes Last Institution: Harvard Medical in Cambridge, MA, Grant Institution: The Regents of the University of California, San Francisco Grant Term: 1/1/2001 through 9/30/2009 Area of Research: Carcinogenesis Current Institution: Swiss Institute for Experimental Cancer Research in Switzerland, Grant Institution: Yale University in New Haven, CT Grant Term: 7/1/1964 through 6/30/1991 Area of Research: Immunopharmacology and studies of mechanisms involved in the modulation of cancer Current Institution: Yale School of Medicine in New Haven, CT, Grant Institution: The Regents of the University of California, Berkeley Grant Term: 1/1/2011 through 12/31/2020 Area of Research: Regulation of Growth and Regeneration in Drosophila Current Institution: University of California, Berkeley Podcast:"Cancer is basically a non-healing wound and we should treat it as such", Grant Institution: Massachusetts General Hospital Grant Term: 1/1/1992 through 11/29/1999 Area of Research: Transformation by DNA Tumor Viruses Current Institution: Harvard Medical School in Cambridge, MA, Grant Institution: University of Washington in Seattle Grant Term: 1/1/1990 through 6/30/1997 Area of Research: Cell Biology Current Institution: Arizona State University in Tempe, AZ Nobel Laureates and the American Cancer Society, Grant Institution: Stowers Institute for Medical Research in Kansas City, MO Grant Term: 1/1/2005 through 12/31/2015 Area of Research: The Origins of Meiotic and Mitotic Aneuploidy Current Institution: Stowers Institute for Medical Research in Kansas City, MO, Grant Institution: Boston Children's Hospital in Massachusetts Grant Term: 1/1/2015 through 12/31/2025 Area of Research: Understanding Wnt and R-spondin Signaling in Stem Cells and Cancer Current Institution: Boston Children's Hospital Health in Massachusetts, Grant Institution: The Regents of the University of Minnesota - Twin Cities Grant Term: 1/1/2000 through 6/30/2010 Area of Research: Carcinogenesis and Cancer Prevention Current Institution: University of Minnesota Masonic Cancer Center in Minneapolis, Grant Institution: University of Wisconsin - Madison Grant Term: 7/1/1960 through 6/30/1991 Area of Research: Molecular Biology Last Institution: University of Southern California, Grant Institution: University of Connecticut in Mansfield Grant Term: 9/15/1960 through 9/14/1980 Area of Research: Molecular Biology Last Institution: University of Connecticut Health in Farmington, Grant Institution:Columbia University in New York City Grant Term:9/1/2020 through 8/31/2025 Area of Research:Cancer Control and Prevention Current Institution:Columbia University in New York City Press Release: American Cancer Society Awards Research Professorships, Grant Institution: University of Kansas in Lawrence, KS Grant Term: 9/1/1961 through 6/30/1993 Area of Research: Epidemiology Last Institution: University of Kansas Health in Kansas City, KS, Grant Institution: University of Virginia in Charlottesville Grant Term: 6/1/1960 through 3/31/1992 Area of Research: Molecular Biology Last Institution: Icahn School of Medicine at Mount Sinai in New York City, NY, Grant Institution: Salk Institute for Biological Studies in La Jolla, CA Grant Term: 1/1/1969 through 3/31/1992 Area of Research: Molecular Biology Last Institution: Salk Institute for Biological Studies in La Jolla, CA Nobel Laureates and the American Cancer Society, Grant Institution: University of Texas M.D.